Related references
Note: Only part of the references are listed.The genomic landscape of Waldenstrom macroglobulinemia is characterized by highly recurring MYD88 and WHIM-like CXCR4 mutations, and small somatic deletions associated with B-cell lymphomagenesis
Zachary R. Hunter et al.
BLOOD (2014)
C1013G/CXCR4 acts as a driver mutation of tumor progression and modulator of drug resistance in lymphoplasmacytic lymphoma
Aldo M. Roccaro et al.
BLOOD (2014)
Somatic mutations in MYD88 and CXCR4 are determinants of clinical presentation and overall survival in Waldenstrom macroglobulinemia
Steven P. Treon et al.
BLOOD (2014)
Expression of CXCR4 and breast cancer prognosis: a systematic review and meta-analysis
Zhigang Zhang et al.
BMC CANCER (2014)
Widespread Genetic Heterogeneity in Multiple Myeloma: Implications for Targeted Therapy
Jens G. Lohr et al.
CANCER CELL (2014)
Heterogeneity of genomic evolution and mutational profiles in multiple myeloma
Niccolo Bolli et al.
NATURE COMMUNICATIONS (2014)
MYD88 L265P in Waldenstrom macroglobulinemia, immunoglobulin M monoclonal gammopathy, and other B-cell lymphoproliferative disorders using conventional and quantitative allele-specific polymerase chain reaction
Lian Xu et al.
BLOOD (2013)
Evolution and Impact of Subclonal Mutations in Chronic Lymphocytic Leukemia
Dan A. Landau et al.
CELL (2013)
Hypoxia promotes dissemination of multiple myeloma through acquisition of epithelial to mesenchymal transition-like features
Abdel Kareem Azab et al.
BLOOD (2012)
Waldenstrom's Macroglobulinemia/Lymphoplasmacytic Lymphoma, Version 2.2013 Featured Updates to the NCCN Guidelines
Kenneth C. Anderson et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2012)
Inhibition of CXCR4 in CML cells disrupts their interaction with the bone marrow microenvironment and sensitizes them to nilotinib
E. Weisberg et al.
LEUKEMIA (2012)
Waldenstrom macroglobulinemia: a Surveillance, Epidemiology, and End Results database review from 1988 to 2005
Jeevan Sekhar et al.
LEUKEMIA & LYMPHOMA (2012)
MYD88 L265P Somatic Mutation in Waldenstrom's Macroglobulinemia
Steven P. Treon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Neuropathy and paraproteins: review of a complex association
Y. A. Rajabally
EUROPEAN JOURNAL OF NEUROLOGY (2011)
Update on Treatment Recommendations From the Fourth International Workshop on Waldenstrom's Macroglobulinemia
Meletios Athanasios Dimopoulos et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
SDF-1/CXCR4 and VLA-4 interaction regulates homing in Waldenstrom macroglobulinemia
Hai T. Ngo et al.
BLOOD (2008)
Schnitzler syndrome: Beyond the case reports: Review and follow-up of 94 patients with an emphasis on prognosis and treatment
Heleen D. de Koning et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2007)
An unusual reoccurrence of Waldenstrom's macroglobulinemia as pleural effusions that had a discordant response with treatment
CJ Amin et al.
CLINICAL AND LABORATORY HAEMATOLOGY (2005)
Waldenstrom macroglobulinemia involving extramedullary sites - Morphologic and immunophenotypic findings in 44 patients
P Lin et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2003)
Uniform response criteria in Waldenstrom's macroglobulinemia:: Consensus panel recommendations from the Second International Workshop on Waldenstrom's macroglobulinemia
D Weber et al.
SEMINARS IN ONCOLOGY (2003)
Clinicopathological definition of Waldenstrom's macroglobulinemia: Consensus panel recommendations from the second international workshop on Waldenstrom's macroglobulinemia
RG Owen et al.
SEMINARS IN ONCOLOGY (2003)
Waldenstrom's macroglobulinemia: Clinical features, complications, and management
MA Dimopoulos et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
Share Paper
